Differential protection of neuromuscular sensory and motor axons and their endings in WldS mutant mice

Neuroscience

Volumn 200, Issue , 2012, Pages 142-158

  Oyebode, O R O ^a   Hartley, R ^a   Singhota, J ^a   Thomson, D ^a   Ribchester, R R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Axon; Motor neurone; Muscle spindle; Neuromuscular junction; Sensory neurone; Wallerian degeneration

Indexed keywords

CYAN FLUORESCENT PROTEIN; YELLOW FLUORESCENT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE DOSAGE; GENE MUTATION; HETEROZYGOTE; HOMOZYGOTE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MOTONEURON; MOUSE; MUSCLE SPINDLE; NERVE DEGENERATION; NERVE ENDING; NERVE FIBER; NEUROMUSCULAR DISEASE; NEUROTOXICITY; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSORIMOTOR FUNCTION; SPINAL GANGLION;

ACTION POTENTIALS; AGE FACTORS; ANIMALS; AXONS; AXOTOMY; BUNGAROTOXINS; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION; GANGLIA, SPINAL; LUMINESCENT PROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOTOR NEURONS; MUTATION; NERVE TISSUE PROTEINS; NEUROMUSCULAR JUNCTION; ORGAN CULTURE TECHNIQUES; PERIPHERAL NERVE INJURIES; PYRIDINIUM COMPOUNDS; QUATERNARY AMMONIUM COMPOUNDS; SENSORY RECEPTOR CELLS; SPINAL CORD;

EID: 84855197588     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.10.020     Document Type: Article

References (72)

1. Adalbert R., Gillingwater T.H., Haley J.E., Bridge K., Beirowski B., Berek L., Wagner D., Grumme D., Thomson D., Celik A., Addicks K., Ribchester R.R., Coleman M.P. A rat model of slow Wallerian degeneration (WldS) with improved preservation of neuromuscular synapses. Eur J Neurosci 2005, 21:271-277.
2. Araki T., Sasaki Y., Milbrandt J. Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 2004, 305:1010-1013.
3. Babetto E., Beirowski B., Janeckova L., Brown R., Gilley J., Thomson D., Ribchester R.R., Coleman M.P. Targeting NMNAT1 to axons and synapses transforms its neuroprotective potency in vivo. J Neurosci 2010, 30:13291-13304.
4. Barker D., Emonet-Dénand F., Harker D.W., Jami L., Laporte Y. Types of intra- and extrafusal muscle fibre innervated by dynamic skeleto-fusimotor axons in cat peroneus brevis and tenuissimus muscles, as determined by the glycogen-depletion method. J Physiol 1977, 266:713-726.
5. Barrientos S.A., Martinez N.W., Yoo S., Jara J.S., Zamorano S., Hetz C., Twiss J.L., Alvarez J., Court F.A. Axonal degeneration is mediated by the mitochondrial permeability transition pore. J Neurosci 2011, 31:966-978.
6. Beirowski B., Adalbert R., Wagner D., Grumme D.S., Addicks K., Ribchester R.R., Coleman M.P. The progressive nature of Wallerian degeneration in wild-type and slow Wallerian degeneration (WldS) nerves. BMC Neurosci 2005, 6:6.
7. Beirowski B., Babetto E., Gilley J., Mazzola F., Conforti L., Janeckova L., Magni G., Ribchester R.R., Coleman M.P. Non-nuclear Wld(S) determines its neuroprotective efficacy for axons and synapses in vivo. J Neurosci 2009, 29:653-668.
8. Beirowski B., Berek L., Adalbert R., Wagner D., Grumme D.S., Addicks K., Ribchester R.R., Coleman M.P. Quantitative and qualitative analysis of Wallerian degeneration using restricted axonal labelling in YFP-H mice. J Neurosci Methods 2004, 134:23-35.
9. Bewick G.S., Reid B., Richardson C., Banks R.W. Autogenic modulation of mechanoreceptor excitability by glutamate release from synaptic-like vesicles: evidence from the rat muscle spindle primary sensory ending. J Physiol 2005, 562:381-394.
10. Bridge K.E., Berg N., Adalbert R., Babetto E., Dias T., Spillantini M.G., Ribchester R.R., Coleman M.P. Late onset distal axonal swelling in YFP-H transgenic mice. Neurobiol Aging 2009, 30:309-321.
11. Brown M.C., Perry V.H., Hunt S.P., Lapper S.R. Further studies on motor and sensory nerve regeneration in mice with delayed Wallerian degeneration. Eur J Neurosci 1994, 6:420-428.
12. Buckmaster E.A., Perry V.H., Brown M.C. The rate of Wallerian degeneration in cultured neurons from wild type and C57BL/WldS mice depends on time in culture and may be extended in the presence of elevated K+ levels. Eur J Neurosci 1995, 7:1596-1602.
13. Caston J., Devulder B., Jouen F., Lalonde R., Delhaye-Bouchaud N., Mariani J. Role of an enriched environment on the restoration of behavioral deficits in Lurcher mutant mice. Dev Psychobiol 1999, 35:291-303.
14. Coleman M.P., Conforti L., Buckmaster E.A., Tarlton A., Ewing R.M., Brown M.C., Lyon M.F., Perry V.H. An 85-kb tandem triplication in the slow Wallerian degeneration (Wlds) mouse. Proc Natl Acad Sci U S A 1998, 95:9985-9990.
15. Coleman M.P., Freeman M.R. Wallerian degeneration, wld(s), and nmnat. Annu Rev Neurosci 2010, 33:245-267.
16. Conforti L., Fang G., Beirowski B., Wang M.S., Sorci L., Asress S., Adalbert R., Silva A., Bridge K., Huang X.P., Magni G., Glass J.D., Coleman M.P. NAD (+) and axon degeneration revisited: Nmnat1 cannot substitute for Wld(S) to delay Wallerian degeneration. Cell Death Differ 2007, 14:116-127.
17. Conforti L., Tarlton A., Mack T.G., Mi W., Buckmaster E.A., Wagner D., Perry V.H., Coleman M.P. A Ufd2/D4Cole1e chimeric protein and overexpression of Rbp7 in the slow Wallerian degeneration (WldS) mouse. Proc Natl Acad Sci U S A 2000, 97:11377-11382.
18. Conforti L., Wilbrey A., Morreale G., Janeckova L., Beirowski B., Adalbert R., Mazzola F., Di Stefano M., Hartley R., Babetto E., Smith T., Gilley J., Billington R.A., Genazzani A.A., Ribchester R.R., Magni G., Coleman M. Wld S protein requires Nmnat activity and a short N-terminal sequence to protect axons in mice. J Cell Biol 2009, 184:491-500.
19. David G., Nguyen K., Barrett E.F. Early vulnerability to ischemia/reperfusion injury in motor terminals innervating fast muscles of SOD1-G93A mice. Exp Neurol 2007, 204:411-420.
20. Desaki J., Ezaki T., Nishida N. Fine structural study of the innervation of muscle spindles in the internal oblique muscle of the abdominal wall in the adult mouse. J Electron Microsc (Tokyo) 2010, 59:243-250.
21. Feng G., Mellor R.H., Bernstein M., Keller-Peck C., Nguyen Q.T., Wallace M., Nerbonne J.M., Lichtman J.W., Sanes J.R. Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 2000, 28:41-51.
22. Ferri A., Sanes J.R., Coleman M.P., Cunningham J.M., Kato A.C. Inhibiting axon degeneration and synapse loss attenuates apoptosis and disease progression in a mouse model of motoneuron disease. Curr Biol 2003, 13:669-673.
23. Fischer L.R., Culver D.G., Davis A.A., Tennant P., Wang M., Coleman M., Asress S., Adalbert R., Alexander G.M., Glass J.D. The WldS gene modestly prolongs survival in the SOD1G93A fALS mouse. Neurobiol Dis 2005, 19:293-300.
24. Fischer L.R., Culver D.G., Tennant P., Davis A.A., Wang M., Castellano-Sanchez A., Khan J., Polak M.A., Glass J.D. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol 2004, 185:232-240.
25. Forero D.A., Casadesus G., Perry G., Arboleda H. Synaptic dysfunction and oxidative stress in Alzheimer's disease: emerging mechanisms. J Cell Mol Med 2006, 10:796-805.
26. Frey D., Schneider C., Xu L., Borg J., Spooren W., Caroni P. Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J Neurosci 2000, 20:2534-2542.
27. Gates H.J., Ridge R.M., Rowlerson A. Motor units of the fourth deep lumbrical muscle of the adult rat: isometric contractions and fibre type compositions. J Physiol 1991, 443:193-215.
28. Gilley J., Coleman M.P. Endogenous Nmnat2 is an essential survival factor for maintenance of healthy axons. PLoS Biol 2010, 8:e1000300.
29. Gillingwater T.H., Ingham C.A., Coleman M.P., Ribchester R.R. Ultrastructural correlates of synapse withdrawal at axotomized neuromuscular junctions in mutant and transgenic mice expressing the Wld gene. J Anat 2003, 203:265-276.
30. Gillingwater T.H., Ribchester R.R. Compartmental neurodegeneration and synaptic plasticity in the Wld(s) mutant mouse. J Physiol 2001, 534:627-639.
31. Gillingwater T.H., Thomson D., Mack T.G., Soffin E.M., Mattison R.J., Coleman M.P., Ribchester R.R. Age-dependent synapse withdrawal at axotomised neuromuscular junctions in Wld(s) mutant and Ube4b/Nmnat transgenic mice. J Physiol 2002, 543:739-755.
32. Hains B.C., Saab C.Y., Lo A.C., Waxman S.G. Sodium channel blockade with phenytoin protects spinal cord axons, enhances axonal conduction, and improves functional motor recovery after contusion SCI. Exp Neurol 2004, 188:365-377.
33. Hoopfer E.D., McLaughlin T., Watts R.J., Schuldiner O., O'Leary D.D., Luo L. Wlds protection distinguishes axon degeneration following injury from naturally occurring developmental pruning. Neuron 2006, 50:883-895.
34. Hultsch D.F., Hertzog C., Small B.J., Dixon R.A. Use it or lose it: engaged lifestyle as a buffer of cognitive decline in aging?. Psychol Aging 1999, 14:245-263.
35. Iwata A., Stys P.K., Wolf J.A., Chen X.H., Taylor A.G., Meaney D.F., Smith D.H. Traumatic axonal injury induces proteolytic cleavage of the voltage-gated sodium channels modulated by tetrodotoxin and protease inhibitors. J Neurosci 2004, 24:4605-4613.
36. Kapoor R., Davies M., Blaker P.A., Hall S.M., Smith K.J. Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration. Ann Neurol 2003, 53:174-180.
37. Kariya S., Mauricio R., Dai Y., Monani U.R. The neuroprotective factor Wld(s) fails to mitigate distal axonal and neuromuscular junction (NMJ) defects in mouse models of spinal muscular atrophy. Neurosci Lett 2009, 449:246-251.
38. Kikuchi T., Mukoyama M., Yamazaki K., Moriya H. Axonal degeneration of ascending sensory neurons in gracile axonal dystrophy mutant mouse. Acta Neuropathol 1990, 80:145-151.
39. Kucera J., Walro J.M., Reichler J. Neural organization of spindles in three hindlimb muscles of the rat. Am J Anat 1991, 190:74-88.
40. Lin Y.C., Koleske A.J. Mechanisms of synapse and dendrite maintenance and their disruption in psychiatric and neurodegenerative disorders. Annu Rev Neurosci 2010, 33:349-378.
41. Lu J., Tapia J.C., White O.L., Lichtman J.W. The interscutularis muscle connectome. PLoS Biol 2009, 7:e32.
42. Lunn E.R., Perry V.H., Brown M.C., Rosen H., Gordon S. Absence of Wallerian degeneration does not hinder regeneration in peripheral nerve. Eur J Neurosci 1989, 1:27-33.
43. Lyon M.F., Ogunkolade B.W., Brown M.C., Atherton D.J., Perry V.H. A gene affecting Wallerian nerve degeneration maps distally on mouse chromosome 4. Proc Natl Acad Sci U S A 1993, 90:9717-9720.
44. MacDonald J.M., Beach M.G., Porpiglia E., Sheehan A.E., Watts R.J., Freeman M.R. The Drosophila cell corpse engulfment receptor Draper mediates glial clearance of severed axons. Neuron 2006, 50:869-881.
45. Mack T.G., Reiner M., Beirowski B., Mi W., Emanuelli M., Wagner D., Thomson D., Gillingwater T., Court F., Conforti L., Fernando F.S., Tarlton A., Andressen C., Addicks K., Magni G., Ribchester R.R., Perry V.H., Coleman M.P. Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nat Neurosci 2001, 4:1199-1206.
46. Martin S.M., O'Brien G.S., Portera-Cailliau C., Sagasti A. Wallerian degeneration of zebrafish trigeminal axons in the skin is required for regeneration and developmental pruning. Development 2010, 137:3985-3994.
47. Meyer zu Horste G., Miesbach T.A., Muller J.I., Fledrich R., Stassart R.M., Kieseier B.C., Coleman M.P., Sereda M.W. The Wlds transgene reduces axon loss in a Charcot-Marie-Tooth disease 1A rat model and nicotinamide delays post-traumatic axonal degeneration. Neurobiol Dis 2011, 42:1-8.
48. Mi W., Beirowski B., Gillingwater T.H., Adalbert R., Wagner D., Grumme D., Osaka H., Conforti L., Arnhold S., Addicks K., Wada K., Ribchester R.R., Coleman M.P. The slow Wallerian degeneration gene, WldS, inhibits axonal spheroid pathology in gracile axonal dystrophy mice. Brain 2005, 128:405-416.
49. Miledi R., Slater C.R. Electrophysiology and electron-microscopy of rat neuromuscular junctions after nerve degeneration. Proc R Soc Lond B Biol Sci 1968, 169:289-306.
50. Oda K., Yamazaki K., Miura H., Shibasaki H., Kikuchi T. Dying back type axonal degeneration of sensory nerve terminals in muscle spindles of the gracile axonal dystrophy (GAD) mutant mouse. Neuropathol Appl Neurobiol 1992, 18:265-281.
51. Ovalle W.K. Fine structure of rat intrafusal muscle fibers. The equatorial region. J Cell Biol 1972, 52:382-396.
52. Oyebode O.R.O. Protection of neuromuscular sensory endings by the WldS gene. University of Edinburgh PhD Thesis 2009.
53. Porayko O., Smith R.S. Morphology of muscle spindles in the rat. Experientia 1968, 24:588-589.
54. Ribchester R.R., Tsao J.W., Barry J.A., Asgari-Jirhandeh N., Perry V.H., Brown M.C. Persistence of neuromuscular junctions after axotomy in mice with slow Wallerian degeneration (C57BL/WldS). Eur J Neurosci 1995, 7:1641-1650.
55. Samsam M., Mi W., Wessig C., Zielasek J., Toyka K.V., Coleman M.P., Martini R. The Wlds mutation delays robust loss of motor and sensory axons in a genetic model for myelin-related axonopathy. J Neurosci 2003, 23:2833-2839.
56. Saxena S., Caroni P. Mechanisms of axon degeneration: from development to disease. Prog Neurobiol 2007, 83:174-191.
57. Schaefer A.M., Sanes J.R., Lichtman J.W. A compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis. J Comp Neurol 2005, 490:209-219.
58. Selkoe D.J. Alzheimer's disease is a synaptic failure. Science 2002, 298:789-791.
59. Slater C.R. Time course of failure of neuromuscular transmission after motor nerve section. Nature 1966, 209:305-306.
60. Swaab D.F., Dubelaar E.J., Hofman M.A., Scherder E.J., van Someren E.J., Verwer R.W. Brain aging and Alzheimer's disease; use it or lose it. Prog Brain Res 2002, 138:343-373.
61. Tourtellotte W.G., Keller-Peck C., Milbrandt J., Kucera J. The transcription factor Egr3 modulates sensory axon-myotube interactions during muscle spindle morphogenesis. Dev Biol 2001, 232:388-399.
62. Tsao J.W., Brown M.C., Carden M.J., McLean W.G., Perry V.H. Loss of the compound action potential: an electrophysiological, biochemical and morphological study of early events in axonal degeneration in the C57BL/Ola mouse. Eur J Neurosci 1994, 6:516-524.
63. Vande Velde C., Garcia M.L., Yin X., Trapp B.D., Cleveland D.W. The neuroprotective factor Wlds does not attenuate mutant SOD1-mediated motor neuron disease. Neuromolecular Med 2004, 5:193-203.
64. von Schlippe M., Fowler C.J., Harland S.J. Cisplatin neurotoxicity in the treatment of metastatic germ cell tumour: time course and prognosis. Br J Cancer 2001, 85:823-826.
65. Wang M.S., Davis A.A., Culver D.G., Glass J.D. WldS mice are resistant to paclitaxel (taxol) neuropathy. Ann Neurol 2002, 52:442-447.
66. Wang M.S., Fang G., Culver D.G., Davis A.A., Rich M.M., Glass J.D. The WldS protein protects against axonal degeneration: a model of gene therapy for peripheral neuropathy. Ann Neurol 2001, 50:773-779.
67. Watanabe M., Tsukiyama T., Hatakeyama S. Protection of vincristine-induced neuropathy by WldS expression and the independence of the activity of Nmnat1. Neurosci Lett 2007, 411:228-232.
68. Wilbrey A.L., Haley J.E., Wishart T.M., Conforti L., Morreale G., Beirowski B., Babetto E., Adalbert R., Gillingwater T.H., Smith T., Wyllie D.J., Ribchester R.R., Coleman M.P. VCP binding influences intracellular distribution of the slow Wallerian degeneration protein, Wld(S). Mol Cell Neurosci 2008, 38:325-340.
69. Winlow W., Usherwood P.N. Ultrastructural studies of normal and degenerating mouse neuromuscular junctions. J Neurocytol 1975, 4:377-394.
70. Winlow W., Usherwood P.N. Electrophysiological studies of normal and degenerating mouse neuromuscular junctions. Brain Res 1976, 110:447-461.
71. Wong F., Fan L., Wells S., Hartley R., Mackenzie F.E., Oyebode O., Brown R., Thomson D., Coleman M.P., Blanco G., Ribchester R.R. Axonal and neuromuscular synaptic phenotypes in Wld(S), SOD1(G93A) and ostes mutant mice identified by fiber-optic confocal microendoscopy. Mol Cell Neurosci 2009, 42:296-307.
72. Wright A.K., Wishart T.M., Ingham C.A., Gillingwater T.H. Synaptic protection in the brain of WldS mice occurs independently of age but is sensitive to gene-dose. PLoS One 2010, 5:e15108.